Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Drug Notebook

FDA Alerts

    Mortality
  • In many antiarrhythmic drug trials for non-life-threatening arrhythmias, active drug treatment was associated with increased mortality.
  • Risk of antiarrhythmic drug therapy probably is greatest in patients with structural heart disease.
  • Pooled analysis of data from several randomized, controlled studies in patients with atrial flutter and fibrillation indicates that quinidine therapy may be associated with a mortality rate 3 times higher compared with that associated with placebo; consider the increased risk of death when initiating quinidine therapy.
  • Pooled analysis of clinical trials showed mortality with quinidine for non-life-threatening ventricular arrhythmias as consistently exceeding that associated with various alternative antiarrhythmic drugs (i.e., flecainide, mexiletine, propafenone, tocainide).
  • Excessive mortality or nonfatal cardiac arrest rate (7.7%) in encainide- or flecainide-treated patients with asymptomatic non-life-threatening ventricular arrhythmias (with MI history >6 days but <2 years) in NHLBI's long-term CAST study relative to placebo.
  • Applicability of CAST findings to other populations (e.g., those without recent MI) uncertain.

Media Gallery
Drug Info Tools
Search by color, shape and markings. click here
Check any 2 drugs for interactions. click here
Compare any two drugs side by side. click here
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
quinidine
(KWIN i deen)
MP 124 | 300 mgMP 124   300 mg
bottle, 100 each Quinidine SO4 300mg, Oral tablet, white, round-shaped, scored, side 1:MP 124
MP 108 | 200 mgMP 108   200 mg
bottle, 100 each Quinidine SO4 200mg, Oral tablet, white, round-shaped, scored, side 1:MP 108
5454 / DAN DAN | 300 mg5454 / DAN DAN   300 mg
bottle, 100 each Quinidine SO4 300mg, Oral tablet, white, round-shaped, scored, side 1:5454, side 2:DAN DAN
E 512 | 300 mgE 512   300 mg
bottle, 100 each Quinidine SO4 300mg, Oral tablet, white, round-shaped, scored, side 1:E 512
MP 108 | 200 mgMP 108   200 mg
bottle, 100 each Quinidine SO4 200mg, Oral tablet, white, round-shaped, scored, side 1:MP 108
5438 / DAN DAN | 200 mg5438 / DAN DAN   200 mg
bottle, 100 each Quinidine SO4 200mg, Oral tablet, white, round-shaped, scored, side 1:5438, side 2:DAN DAN
MP 124 | 300 mgMP 124   300 mg
bottle, 100 each Quinidine SO4 300mg, Oral tablet, white, round-shaped, scored, side 1:MP 124
DAN DAN / 5454 | 300 mgDAN DAN / 5454   300 mg
bottle, 100 each Quinidine SO4 300mg, Oral tablet, white, round-shaped, scored, side 1:DAN DAN, side 2:5454
E 511 | 200 mgE 511   200 mg
bottle, 100 each Quinidine SO4 200mg, Oral tablet, white, round-shaped, scored, side 1:E 511
Back to Top